2019.04.16
License Agreement Has Been Entered into with Heartseed Inc.
License-Out
We have executed a worldwide license agreement with Heartseed Inc. (Tokyo, Japan) for the use of iPS cell-derived cardiomyocytes products for regenerative therapy under the patents on iPS cell related technologies licensed to us by Kyoto University.